Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00181168
Status:
COMPLETED
Last Update Posted:
2018-11-02
First Post:
2005-09-12
Brief Title:
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Study Overview
Official Title:
Utility of Recombinant Human Thyrotropin rTSH PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine for patients with previously treated well-differentiated thyroid cancer and evidence of residual disease based on serum thyroglobulin Tg level whether positron emission tomography-computed tomography PET-CT fusion scanning performed after recombinant thyroid-stimulating hormone TSH rTSH thyrotropin alfa for injection will be more sensitive for the detection of disease sites than PET-CT scanning without rTSH The study will also determine if this information will significantly alter the therapeutic approach in some patients
Detailed Description:
PETCT was performed before basal PET and 24 - 48 h after rhTSH administration rhTSH-PET in 63 patients 52 papillary and 11 follicular thyroid cancers Images were blindly analyzed by two readers The proposed treatment plan was prospectively assessed before basal PET after basal PET and again after rhTSH-PET
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| JHM IRB 1 | OTHER | Johns Hopkins University | None |